Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Cash from Financing Activities (2021 - 2023)

Updated

Nika Pharmaceuticals (NIKA) reported Cash from Financing Activities of $10,000 for Q3 2023, up 211.7% from $3,208 a year earlier but down 70.9% from the prior quarter.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Cash from Financing Activities (2021 - 2023) Analysis & Trends

Over the twelve months ended Sep 30, 2023, Nika Pharmaceuticals' Cash from Financing Activities came in at $79,565, up 229.1% year-over-year; for FY2022, it came in at $34,180, up 153.2% from FY2021.

  • By year, Cash from Financing Activities came in at $13,500 in FY2021.
  • Five-year quarterly Cash from Financing Activities spans a low of $2,000 in Q2 2021 and a high of $34,400 in Q2 2023.
  • Year over year, Cash from Financing Activities has now increased in each of the last four quarters, with growth averaging 243.0% over the last seven quarters.
  • Per Business Quant data, the three quarters before Q3 2023 came in at $34,400 (Q2 2023), $23,165 (Q1 2023) and $12,000 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 10,000.00
Jun 30, 2023 34,400.00
Mar 31, 2023 23,165.00
Dec 31, 2022 12,000.00
Sep 30, 2022 3,208.00
Jun 30, 2022 12,972.00
Mar 31, 2022 6,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 4,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 5,500.00
API Access

Nika Pharmaceuticals, Inc Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NIKA&period=max&api_key=YOUR_API_KEY